NEW YORK (GenomeWeb) - CombiMatrix reported after the close of the market on Wednesday a 23 percent jump in third quarter revenues.

For the three-month period ended Sept. 30, CombiMatrix's revenues rose to $2.5 million from $2.1 million in the prior-year period.

In a statement, CombiMatrix CEO Mark McDonough said the firm "[continues] to perform and execute on key metrics in terms of driving testing volumes, adding new customers, securing reimbursement contracts, collecting cash, and entering and developing key markets."

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

360Dx reports that the US Centers for Medicare & Medicaid Services would cover next-generation sequencing-based cancer panel tests.

The Washington Post reports that a meteorologist is being considered as presidential science and technology advisor.

In PNAS this week: precision medicine strategy to screen for disease risk, genome evolution in Haemophilus influenzae, and more.

Researchers have developed a PCR-based assay to gauge whether manatees are present in waters.